Cite
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.
MLA
Persky, Daniel O., et al. “Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.” Journal of Clinical Oncology, vol. 38, no. 26, Sept. 2020, pp. 3003–11. EBSCOhost, https://doi.org/10.1200/JCO.20.00999.
APA
Persky, D. O., Li, H., Stephens, D. M., Park, S. I., Bartlett, N. L., Swinnen, L. J., Barr, P. M., Winegarden III, J. D., Constine, L. S., Fitzgerald, T. J., Leonard, J. P., Kahl, B. S., LeBlanc, M. L., Song, J. Y., Fisher, R. I., Rimsza, L. M., Smith, S. M., Miller, T. P., Friedberg, J. W., & Winegarden, J. D., 3rd. (2020). Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. Journal of Clinical Oncology, 38(26), 3003–3011. https://doi.org/10.1200/JCO.20.00999
Chicago
Persky, Daniel O., Hongli Li, Deborah M. Stephens, Steven I. Park, Nancy L. Bartlett, Lode J. Swinnen, Paul M. Barr, et al. 2020. “Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.” Journal of Clinical Oncology 38 (26): 3003–11. doi:10.1200/JCO.20.00999.